Tonix Pharmaceuticals Holding Dividend
Dividend criteria checks 0/6
Tonix Pharmaceuticals Holding does not have a record of paying a dividend.
Key information
n/a
Dividend yield
n/a
Payout ratio
Industry average yield | 2.9% |
Next dividend pay date | n/a |
Ex dividend date | n/a |
Dividend per share | n/a |
Earnings per share | -US$1.22 |
Dividend yield forecast in 3Y | n/a |
Recent dividend updates
No updates
Recent updates
Tonix stock rises on FDA nod to start trial of TNX-601 for depression
Oct 03Tonix Pharmaceuticals GAAP EPS of -$1.22 beats by $0.23
Aug 08Tonix announces partnership to study monkeypox vaccine in 1H 2023
Jul 28Tonix Pharma to develop extended-release form of depression therapy
Jul 11Is Tonix Pharma's Stock A Buy Or Sell After Buyback Plan Announcement?
Jun 21Stability and Growth of Payments
Fetching dividends data
Stable Dividend: Insufficient data to determine if TNXP's dividends per share have been stable in the past.
Growing Dividend: Insufficient data to determine if TNXP's dividend payments have been increasing.
Dividend Yield vs Market
Tonix Pharmaceuticals Holding Dividend Yield vs Market |
---|
Segment | Dividend Yield |
---|---|
Company (TNXP) | n/a |
Market Bottom 25% (US) | 1.6% |
Market Top 25% (US) | 4.8% |
Industry Average (Biotechs) | 2.9% |
Analyst forecast in 3 Years (TNXP) | n/a |
Notable Dividend: Unable to evaluate TNXP's dividend yield against the bottom 25% of dividend payers, as the company has not reported any recent payouts.
High Dividend: Unable to evaluate TNXP's dividend yield against the top 25% of dividend payers, as the company has not reported any recent payouts.
Earnings Payout to Shareholders
Earnings Coverage: Insufficient data to calculate TNXP's payout ratio to determine if its dividend payments are covered by earnings.
Cash Payout to Shareholders
Cash Flow Coverage: Unable to calculate sustainability of dividends as TNXP has not reported any payouts.